The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References

Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below. 

1 – Joanna Hellmuth, Gil D. Rabinovici, and Bruce L. Miller, Journal of the American Medical Association 321, no. 6, 543–44, January 2019

The Rise of Pseudomedicine for Dementia and Brain Health

2 – Koichiro Mori et al., Phytotherapy Research 23, no. 3, 367–72, March 2009

Improving Effects of the Mushroom Yamabushitake (Hericium Erinaceus) on Mild Cognitive Impairment: A Double-Blind Placebo-Controlled Clinical Trial

3 – Yan Li et al., Journal of Pharmacy and Pharmacology 59, no. 4, 503–11, April 2007

Transport and Metabolism of MitoQ10, a Mitochondria‐Targeted Antioxidant, in Caco‐2 Cell Monolayers

4 – Adrian C. Lo et al., Neurobiology of Disease 50, no. 1, 21–9, February 2013

Tauroursodeoxycholic Acid (TUDCA) Supplementation Prevents Cognitive Impairment and Amyloid Deposition in APP/PS1 Mice